OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL

Obesity is a risk factor for development of atrial fibrillation (AF). The impact on stroke outcomes in patients with AF is unknown. We investigated stroke outcomes in normal weight ([NW] BMI 18.50-24.99 kg/m2), overweight ([OW] BMI 25.00-29.99kg/m2), and obese ([OB] BMI ≥30 kg/m2) patients with AF